КИМ, Таэ-Кёнг (KR),У, Чон Вон (KR),ЛИ, Чоан Юн Чи (KR),АНХ, Ёун-Джо (KR),ЧХА, Чи-Ын (KR),РХИМ, Хуё Ёун (KR),ЧАН, У Ик (KR)
申请号：
RU2019109154
公开号：
RU2019109154A
申请日:
2017.08.30
申请国别(地区):
RU
年份:
2020
代理人:
摘要：
The present disclosure relates to a method for administering a human growth hormone fusion protein (GX-H9) for treating growth hormone deficiency. Specifically, the present disclosure relates to a pharmaceutical composition for treating growth hormone deficiency, which comprises an hGH fusion protein (GX-H9) and a pharmaceutically acceptable carrier, wherein the fusion protein (GX-H9) is administered once a week at a dose of 0.4 to 1.6 mg per body weight kg of a pediatric patient, or administered once every two weeks at a dose of 0.8 to 3.2 mg per body weight kg of a pediatric patient. In addition, the present disclosure relates to a method for treating growth hormone deficiency, which comprising a step of administering an hGH fusion protein (GX-H9) to a patient with growth hormone deficiency once a week at a dose of 0.4 to 1.6 mg per body weight kg of the patient, or once every two weeks at a dose of 0.8 to 3.2 mg per body weight kg of the patient.
